
Laurus Labs

Working at Laurus Labs
Company Summary
Overall Rating

10% above

Highly rated for 
Job security, Company culture, Salary
Work Policy




Top Employees Benefits
About Laurus Labs

Laurus Labs is a global leader in APIs & FDF. Our position was strengthened by our backward-integration capability while remaining highly regulatory compliant across all operations.
We emerged as one of the most trusted and largest pharmaceutical Contract Development & Manufacturing Organizations (CDMO) in India for both generics and the proprietary space.
While small-molecule chemistry is ingrained in our DNA, Laurus Labs recognizes the potential and differential benefits of large molecules, namely biologicals and biotechnology products, in the healthcare and nutritional space. We permeated this domain with the inception of Laurus Bio and continue the commitment by investing and collaborating in Cell and Gene therapies.

ABECA - AmbitionBox Employee Choice Awards



Laurus Labs Ratings
Overall Rating





Category Ratings
Job security
Company culture
Salary
Work-life balance
Skill development
Work satisfaction
Promotions
Work Policy at Laurus Labs



Laurus Labs Reviews
Top mentions in Laurus Labs Reviews
Compare Laurus Labs with Similar Companies
![]() | ![]() Change Company | ![]() Change Company | ![]() Change Company | |
---|---|---|---|---|
Overall Rating | 4.3/5 based on 2.1k reviews | 4.0/5 based on 7.4k reviews | 4.1/5 based on 6.6k reviews | 4.1/5 based on 7.6k reviews |
Highly Rated for | Job security Salary Company culture | Skill development Salary Work-life balance | Skill development Company culture Work-life balance | Skill development Salary Work-life balance |
Critically Rated for | ![]() No critically rated category | Promotions | ![]() No critically rated category | ![]() No critically rated category |
Primary Work Policy | Work from office 91% employees reported | Work from office 73% employees reported | Work from office 82% employees reported | Work from office 74% employees reported |
Rating by Women Employees | 4.1 Good rated by 154 women | 3.9 Good rated by 849 women | 4.1 Good rated by 413 women | 4.0 Good rated by 772 women |
Rating by Men Employees | 4.3 Good rated by 1.8k men | 4.0 Good rated by 6.2k men | 4.1 Good rated by 5.9k men | 4.1 Good rated by 6.4k men |
Job security | 4.3 Good | 3.5 Good | 3.7 Good | 3.7 Good |
Laurus Labs Salaries
Associate 4

Associate 3

Associate2

Chemist

Associate 5

Associate L2

Deputy Manager

Research Associate

Production Chemist

Executive Level 2

Laurus Labs Interview Questions
Laurus Labs Jobs
Laurus Labs News
Five Stocks To Buy: Bandhan Bank, Cipla, Sona BLW, Rain Industries, Laurus Labs
- Analysts recommend buying stocks such as Bandhan Bank, Cipla, Sona BLW, Rain Industries, and Laurus Labs for Friday's trade session.
- Recommendations were provided by analysts like Osho Krishnan, Nilesh Jain, and Akshay P Bhagwat.
- Target prices and stop losses were given for each stock, with potential upside percentages mentioned.
- The stocks selected span across financial services, pharma, chemicals, and automobile component sectors.

Stocks To Buy Or Sell: Ajit Mishra's Top Picks For June 17
- Ajit Mishra, senior vice president of Research at Religare Broking, recommended Tata Consultancy Services and Laurus Labs as top stock picks for June 17, 2025.
- Nifty 50 and BSE Sensex started the day in the green with Nifty Defence and Nifty IT leading gains.
- As of midday, Nifty 50 was trading 0.19% higher at 24,898.45, and Sensex 30 was 0.17% higher at 81,647.96.
- Tata Consultancy Services was advised for a buy at Rs 3,496.2 with a target price of Rs 3,520 and a stop loss at Rs 3,430.
- Laurus Labs was suggested as a buy at Rs 679.85 with a target price of Rs 705 and a stop loss at Rs 658.
- 36 out of 50 analysts recommend buying Tata Consultancy Services stock with an average 12-month consensus price target implying a 7.4% upside.
- 7 out of 16 analysts suggest buying Laurus Labs stock despite an average 12-month consensus price target indicating a 7.7% downside.
- Investors are advised to consult with their financial adviser before making any investment decisions.

Bandu’s Blockbusters for June 15, 2025
- Bandu, a young investor, picks five stocks weekly that he believes will perform well in the coming week.
- Readers are invited to guess which stock will give the best return by the following Friday (BSE prices).
- Submissions with the predicted stock and price rise should be emailed to bandublockbuster@gmail.com by Wednesday noon.
- The selected winner will receive a prize of ₹2,000.
- Bandu's stock picks for this week are Narayana Hrudayalaya, Biocon, Max Healthcare Institute, Glenmark Pharmaceuticals, and Supreme Petrochem.
- The previous week's winner was Hina Bheda, with the winning stock being Laurus Labs.
- Laurus Labs saw a return of 3.92% from a closing price of ₹641.80 on Jun 6 to ₹666.95 on Jun 13.
- Published on June 14, 2025.

Stocks To Buy: Action Construction, Computer Age Management, Container Corp, Jubilant Pharmova, Laurus Labs
- Analysts have made 'buy' recommendations on stocks from various industries including pharma, automobile manufacturing, and shipping.
- Stocks recommended for buying are Action Construction Equipment Ltd., Container Corp of India, Jubilant Pharmova, Computer Age Management Services Ltd., and Laurus Labs Ltd.
- Target prices and potential upsides were provided for each recommended stock by different analysts.
- Action Construction, Container Corp, Jubilant Pharmova, Computer Age Management Services, and Laurus Labs have been suggested for buying based on analysts' assessments.

Heard On The Street: Dealers Spot Action In PB Fintech, Delhivery, Anant Raj, Lupin, UPL, Among Others
- Dealers spotted potential block deals in PB Fintech and Delhivery, while Anant Raj may announce fundraise through qualified institutional placement route.
- Astra Microwave's board to meet on May 20 for a fundraise consideration, Lupin and UPL witnessed a lot of buying interest from large HNIs.
- HUDCO, Laurus Labs, and SRF observed buy flows on mutual fund desk, and FII desks engaged in basket buying of two-wheeler OEM names like Bajaj Auto, Eicher Motors, and Hero Moto.
- The information provided in NDTV Profit's 'Heard On The Street' is based on dealing room channel checks and should not be considered as financial advice.

Dividends And Stock Splits This Week — Oberoi Realty, Varun Beverages, Bajaj Finance; Track Record Dates
- Companies like Oberoi Realty, Varun Beverages, Anand Rathi Wealth, and Bajaj Finance are set to trade ex-dividend this week, with upcoming record dates for dividends and stock splits.
- Investors must closely monitor record dates to be eligible for dividends as per India's T+1 settlement cycle, ensuring purchases are made before the ex-dividend date for entitlement.
- Oberoi Realty has declared an interim dividend of Rs 2 per share, with a record date of May 5, while Varun Beverages announced an interim dividend of Rs 0.50 per share, with a record date of May 7.
- Bajaj Finance declared a special dividend of Rs 12 per share, attributing it to an exceptional gain from the sale of investment in Bajaj Housing Finance Ltd.
- Other companies announcing dividends this week include Anand Rathi Wealth, Transformer and Rectifiers (India) Ltd., UCO Bank, Oracle Financial Services Software Ltd., Laurus Labs Ltd., Sundaram Fasteners Ltd., and Bank of Maharashtra.
- Stock splits are also on the agenda with Info Edge (India) Ltd., Rajasthan Tube Manufacturing Co., Navkar Urbanstructure Ltd., and Shantai Industries Ltd. planning face value changes in their shares.
- Investors should take note of the specific record dates mentioned for each company announcing dividends and stock splits to ensure eligibility and adjust their investment strategies accordingly.
- Overall, the week ahead presents various opportunities for investors to capitalize on dividends and potential stock split benefits as part of corporate actions by these companies.

Laurus Labs Q4 profit rises 3-fold to ₹234 cr; revenue at ₹1,440 cr
- Laurus Labs recorded a net profit of ₹234 crore in Q4, a three-fold increase from the previous year.
- The revenue for the fourth quarter increased to ₹1,720 crore compared to ₹1,440 crore in the year-ago period.
- For the fiscal year 2024-25, the company reported a profit of ₹358 crore, up from ₹161 crore in the previous year.
- The revenue for the last fiscal year increased to ₹5,554 crore compared to ₹5,041 crore in 2023-24.

Six Stock In News At Noon: Laurus Labs, Bharat Forge, Vedanta, Among Others
- Benchmark indices decline with Nifty 50 trading 1.06% lower at 23,003 and Sensex down 0.81% at 75,677.63.
- Laurus Labs stocks decline by 9.53% as US plans to impose tariffs on the pharma sector.
- Bharat Forge stock falls by 8.83% following the US imposition of a 25% tariff on auto imports.
- Vedanta stock marks the largest decline in the metal sector, falling by 8.20%.

Stocks that will see action today: March 7, 2025
- Aarti Drugs received an Administrative Warning letter from SEBI for violation of Insider Trading Regulations, 2015.
- K&R Rail Engineering secured an order from Indian Port Rail and Ropeway Corporation Limited for projects ranging from Rs 50 to 5000 crore.
- IIFL Facilities Services purchased additional shares of Avanti Feeds for Rs 470 crore.
- NCLAT issued a notice to Ambuja Cements over a plea by Alok Sanghi regarding insolvency proceedings.
- Coromandel International opened a new sulphur manufacturing plant in Andhra Pradesh to double its capacity.
- BEL received additional orders worth ₹577 crore, bringing its total order book for FY25 to over ₹13,000 crore.
- Jay Bharat Maruti increased its shareholding in JBM OGIHARA Die-Tech to 49% by acquiring equity stake.
- KPIL secured new orders worth Rs 2,306 crore, increasing its total order book to Rs 22,500 crore.
- Laurus Labs approved investment of Rs 83.30 crore in joint venture KRKA Pharma for setting up a new manufacturing facility.
- Biocon Biologics collaborated with Civica Inc. to supply Insulin Aspart drug substance for enhancing access and affordability in the US.


Laurus Labs Offices
Compare Laurus Labs with




















Contribute & help others!
Companies Similar to Laurus Labs












Laurus Labs FAQs


Reviews
Interviews
Salaries
Users

